Anthony Fauci Stephen Hahn covid-19 Coronavirus FDA Anthony Fauci Stephen Hahn

FDA expected to quickly approve experimental coronavirus drug Remdesivir: U.S. official

Reading now: 394
globalnews.ca

The nation’s top infectious diseases expert says he expects the U.S. Food and Drug Administration to quickly approve a new experimental drug that showed promising signs in treating patients with COVID-19.

Anthony Fauci tells NBC’s Today show Thursday that he anticipates the go-ahead for the emergency use of Remdesivir to happen “really quickly.” He says he spoke with FDA Commissioner Stephen Hahn on Wednesday, and while Hahn had yet to make a final decision, “I would project that we’re going to be seeing that reasonably soon.” The drug was shown in a major study to shorten recovery time of hospitalized patients.

Fauci said the drug’s manufacturer has committed to scaling production of the drug as quickly as possible as the world hunts for

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA